Introducing the Treatment Attitude Profile (TAP) Scale for Placebo Response Persona Discovery Using Attractor AI Technologies: Applications in Clinical Trial Patient Enrichment

The power of NetraAI: Precision medicine in oncology through sub-insight learning from small data sets

NetraAI-driven discovery of novel biomarkers in MSI-high colon cancer for precision immunotherapy

Using NetraAI to Discover Parkinson’s Disease Subtypes: Generative AI Reveals Transcriptomic Personas Linking Mitochondrial, Microbiome, and Immune Signaling

Evaluating Drug Efficacy: Leveraging Machine Learning Insights For Placebo Response Modeling

Identifying Efficacy Variables for the Use of Escitalopram in Mild Major Depression Disorder (MDD): Implications for Treatment-Resistant MDD Trials

NetraAI: Understanding Patient Populations Beyond Disease Labels for De-Risking Clinical Trials with Large Language Models

Uncovering an Association Between Oligodendroglioma and the Human Papillomavirus (HPV) Through Molecular Subpopulation Analysis Using NetraAI

Understanding treatment response in pancreatic cancer: NetraAI provides genetic differentiation in FOLFIRINOX and Gemcitabine response

Using AI on Data from Anxiety and Schizophrenia Trials to Identify Causal Clusters of Variables for Drug & Placebo Response Via Long Range Memory to Improve Clinical Trial Outcomes

Using NetraAI Hypothesis-Generation for Patient Stratification and Target Discovery in ALS

NetraAI Reveals Subpopulations of Bulbar and Limb ALS Using Transcriptomic Analysis